Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2

Pharmacology

Volumn 87, Issue 3-4, 2011, Pages 135-143

  Fitzpatrick, Leo R ^a   Green, Cecelia ^b   Maines, Lynn W ^b   Smith, Charles D ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b APOGEE BIOTECHNOLOGY CORPORATION   (United States)

Author keywords

Apoptosis; Osteoarthritis; Sphingosine kinase

Indexed keywords

ABC 294640; IODOACETIC ACID; PHOSPHOTRANSFERASE INHIBITOR; PROTEOGLYCAN; SPHINGOSINE KINASE 2; TRAMADOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL RAT; HISTOCHEMISTRY; KNEE; MALE; NICK END LABELING; NONHUMAN; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; RAT;

ADAMANTANE; ANIMALS; APOPTOSIS; CHONDROCYTES; DISEASE MODELS, ANIMAL; IODOACETATES; MALE; OSTEOARTHRITIS; PAIN; PAIN MEASUREMENT; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PYRIDINES; RATS; RATS, WISTAR;

EID: 79951855994     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323911     Document Type: Article

References (25)

1. Altmann RD: Early management of osteoarthritis. Am J Manag Care 2010; 16(suppl): S41-S47.
2. Martel-Pelletier J, Boileu C, Pelletier JP, Roughley PJ: Cartilage in normal and osteoarthritic conditions. Best Pract Res Clin Rheumatol 2008; 22: 351-384.
3. Chandran P, Pai M, Blomme EA, Hsieh GC, Decker MW, Honore P: Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. Eur J Pharmacol 2009; 613: 39-45.
4. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K: Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005; 114: 339-346. (Pubitemid 40385873)
5. Combe R, Bramwell S, Field MJ: The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats? Neurosci Lett 2004; 370: 236-240. (Pubitemid 39370885)
6. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, Winter J: Pain related behavior in two models of osteoarthritis in the rat knee. Pain 2004; 112: 83-93. (Pubitemid 39371023)
7. Janusz MJ, Hoofkin EB, Heitmeyer SA, Woessnert JF, Freemont AJ, Hoyland JA, Brown KK, Hsieh LC, Almstead NG, De B, Natchus MG, Pikul S, Taiwo YO: Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis Cartilage 2001; 9: 751-760. (Pubitemid 33076767)
8. Bove SE, Calcatera SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS: Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis and Cartilage 2003; 11: 821-830. (Pubitemid 37407598)
9. Del Carlo M, Loeser RF: Cell death in osteoarthritis. Curr Rheumatol Rep 2008; 10: 37-42.
10. Watrin-Pinzano A, Etienne S, Grossin L, Gaborit N, Cournil-Henrionnet C, Mainard D, Netter P, Gillet P, Galois L: Increased apoptosis in rat osteoarthritic cartilage corresponds to degenerative chondral lesions and concomitant expression of caspase-3. Biorheology 2006; 43: 403-412. (Pubitemid 44221921)
11. Olivera A, Spiegel S: Sphingosine kinase: a mediator of vital cellular functions. Prostaglandins 2001; 64: 123-134. (Pubitemid 32452286)
12. Maceyka M, Sankkala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH, Milstein S, Spiegel S: Sphk1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 2005; 280: 37118-37129. (Pubitemid 41587796)
13. Karliner JS: Sphingosine kinase regulation and cardioprotection. Cardiovasc Res 2009; 82: 184-192.
14. Limaye V, Xia P, Hahn C, Smith M, Vadas MA, Pitson SM, Gamble JR: Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cell Mol Biol Lett 2009; 14: 424-441.
15. Lai WQ, Inwan AW, Goh HH, Howe HS, Yu DT, Valle-Onate R, McInnes IB, Melendez AJ, Leung BP: Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 2008; 181: 8010-8017.
16. Baker DA, Barth J, Chang R, Obeid LM, Gilekson GS: Genetic sphingosine 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-α-induced arthritis. J Immunol 2010; 185: 2570-2579.
17. French KJ, Zhuang Y, Maines LW, Gao P, Wang W, Beljanski V, Upson JJ, Green CL, Keller SN, Smith CD: Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther 2010; 333: 129-139.
18. Fitzpatrick LR, Green C, Frauenhoffer EE, French KJ, Zhuand Y, Maines LW, Upson JJ, Paul E, Donahue H, Mosher TJ, Smith CD: Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase. Inflammopharmacology 2010, E-pub ahead of print.
19. Beyreuther B, Callizot N, Stohr T: Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model of osteoarthritis pain. Arthritis Res Ther 2007; 9:R14.
20. Cifuentes CJ, Rocha LG, Silva LA, Brito AC, Rueff-Barosso CR, Porto LC, Pinho RA: Decrease in oxidative stress and histological changes induced by physical exercise calibrated in rats with osteoarthritis induced by monosodium iodoacetate. Osteoarthritis Cartilage 2010; 18: 1088-1095.
21. Coste O, Brennels C, Linke B, Pierre S, Mauerer C, Becker W, Schmidt H, Gaio W, Geisslinger G, Scholich K: Sphingosine-1 phosphate modulates spinal nociceptive processing. J Biol Chem 2008; 283: 32442-32451.
22. Al-Saffar FJ, Ganabadi S, Yaakub H, Fakurazi S: Collagenase and sodium-iodoacetateinduced experimental osteoarthritis model in Sprague Dawley rats. Asian J Sci Res 2009; 2: 167-179.
23. Del Valle L, Ochalon A, Cohen S, Patoka R, Zozulya G, Barer F, Atar E, Pina-Oveido S, Perez-Liz G, Castel D, Fishman P: Induction of anti-inflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment. Arthritis Rheum 2009; 60: 3061-3071.
24. Lee SW, Lee HJ, Chung WT, Choi SM, Rhyu SH, Kim DK, Kim KT, Kim JY, Kim JM, Yoo YH: TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. Arthritis Rheum 2004; 50: 434-442.
25. Petak I, Vernes R, Szucs KS, Anozie M, Izeradjene K, Douglas L, Tillman DM, Phillips DC, Houghton JA: A caspase-8-independent component in TRAIL/Apo-2-l-induced cell death in human rhabdomyosarcoma cells. Cell Death Differ 2003; 10: 729-739. (Pubitemid 36675734)